COVID 19 Vaccine AstraZeneca

Disclaimer: The information on this page is intended for Healthcare Professionals only.

The Institute for Medicines and Medical Devices of Montenegro (CInMED) is 05.03.2021. issued a conditional permit for the COVID-19 Vaccine AstraZeneca vaccine.

This drug is under additional monitoring. This allows new security information to be discovered quickly. Healthcare professionals should report any suspected side effects of this drug.

For how to report adverse reactions, see section 4.8. Summary of Product Characteristics, CInMED website or text below this page.



Please report any suspected adverse reactions after administration of the vaccine to the Institute of Public Health of Montenegro (IJZ CG) and / or the Institute of Medicines and Medical Devices (CInMED), using the appropriate form. You can download the form from the CInMED portal ( and send it by mail, fax or e-mail to the following addresses:

  • Institute of Public Health of Montenegro (IJZCG) Džona Džeksona bb, 81 000 Podgorica, Fax: 020 243 728, E-mail:
  • Institute for Medicines and Medical Devices (CInMED) Bulevar Ivana Crnojevića 64a, 81 000 Podgorica, Fax: 020 310 581, E-mail:

You can also report suspected adverse reactions via IS health care (if you have access to the application for reporting adverse events after immunization), or via the application for online reporting, which is accessed via the CInMED portal ( When reporting a suspected adverse reaction, be sure to provide the brand name and serial number of the vaccine used.

Additionally, you can report any suspected adverse reactions to the holder of the marketing authorisation for COVID-19 Vaccine AstraZeneca in Serbia using the links below:


AstraZeneca Reporting

exit ramp cf


You are now leaving

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed